429 related articles for article (PubMed ID: 18791122)
1. Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.
Mimeault M; Batra SK
Gut; 2008 Oct; 57(10):1456-68. PubMed ID: 18791122
[TBL] [Abstract][Full Text] [Related]
2. New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence.
Mimeault M; Batra SK
Histol Histopathol; 2010 Aug; 25(8):1057-73. PubMed ID: 20552555
[TBL] [Abstract][Full Text] [Related]
3. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.
Mimeault M; Batra SK
Pharmacol Rev; 2010 Sep; 62(3):497-524. PubMed ID: 20716670
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.
Mimeault M; Hauke R; Mehta PP; Batra SK
J Cell Mol Med; 2007; 11(5):981-1011. PubMed ID: 17979879
[TBL] [Abstract][Full Text] [Related]
5. Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.
Mimeault M; Mehta PP; Hauke R; Batra SK
Endocr Rev; 2008 Apr; 29(2):234-52. PubMed ID: 18292464
[TBL] [Abstract][Full Text] [Related]
6. Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.
Mimeault M; Batra SK
Mol Aspects Med; 2014 Oct; 39():3-32. PubMed ID: 23994756
[TBL] [Abstract][Full Text] [Related]
7. Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.
Mimeault M; Batra SK
Mol Med; 2011; 17(9-10):949-64. PubMed ID: 21607288
[TBL] [Abstract][Full Text] [Related]
8. Great promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapies.
Mimeault M; Batra SK
Adv Exp Med Biol; 2012; 741():171-86. PubMed ID: 22457110
[TBL] [Abstract][Full Text] [Related]
9. How to make insulin-producing pancreatic β cells for diabetes treatment.
Lu J; Xia Q; Zhou Q
Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
[TBL] [Abstract][Full Text] [Related]
10. Stem cell applications in diabetes.
Noguchi H
J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
[TBL] [Abstract][Full Text] [Related]
11. Recent progress on tissue-resident adult stem cell biology and their therapeutic implications.
Mimeault M; Batra SK
Stem Cell Rev; 2008; 4(1):27-49. PubMed ID: 18288619
[TBL] [Abstract][Full Text] [Related]
12. Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.
Mimeault M; Batra SK
Anticancer Agents Med Chem; 2010 Feb; 10(2):137-51. PubMed ID: 20184544
[TBL] [Abstract][Full Text] [Related]
13. Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell.
Nakamura T; Fujikura J; Inagaki N
J Diabetes Investig; 2021 Feb; 12(2):143-145. PubMed ID: 32654418
[TBL] [Abstract][Full Text] [Related]
14. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
Dadheech N; James Shapiro AM
Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
[TBL] [Abstract][Full Text] [Related]
15. Stem cells: a promising source of pancreatic islets for transplantation in type 1 diabetes.
Street CN; Rajotte RV; Korbutt GS
Curr Top Dev Biol; 2003; 58():111-36. PubMed ID: 14711014
[TBL] [Abstract][Full Text] [Related]
16. Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.
Mimeault M; Batra SK
Panminerva Med; 2008 Mar; 50(1):3-18. PubMed ID: 18427384
[TBL] [Abstract][Full Text] [Related]
17. Stem Cell Therapy for the Management of Type 1 Diabetes: Advances and Perspectives.
Goyal P; Malviya R
Endocr Metab Immune Disord Drug Targets; 2024; 24(5):549-561. PubMed ID: 37861029
[TBL] [Abstract][Full Text] [Related]
18. Stem-cell therapy for diabetes cure: how close are we?
Hardikar AA; Lees JG; Sidhu KS; Colvin E; Tuch BE
Curr Stem Cell Res Ther; 2006 Sep; 1(3):425-36. PubMed ID: 18220886
[TBL] [Abstract][Full Text] [Related]
19. Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes.
Street CN; Sipione S; Helms L; Binette T; Rajotte RV; Bleackley RC; Korbutt GS
Int J Biochem Cell Biol; 2004 Apr; 36(4):667-83. PubMed ID: 15010331
[TBL] [Abstract][Full Text] [Related]
20. Stem cells therapy for type 1 diabetes.
Lü P; Liu F; Yan L; Peng T; Liu T; Yao Z; Wang CY
Diabetes Res Clin Pract; 2007 Oct; 78(1):1-7. PubMed ID: 17349714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
